Massive AML trial aims to find best chemo and transplant protection for younger patients
NCT ID NCT02416388
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This study tests different chemotherapy doses and a drug to prevent graft-versus-host disease in adults aged 18 to 60 with newly diagnosed acute myeloid leukemia. Participants receive either idarubicin or daunorubicin during initial chemo, followed by high or intermediate doses of cytarabine. Those who get a stem cell transplant also receive either standard or mycophenolate mofetil to prevent complications. The goal is to find the best combination to improve survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- chemotherapy drugs (idarubicin, daunorubicin, cytarabine) and mycophenolate mofetil for GvHD prevention
- What this could lead to
- If successful, this could establish better chemotherapy regimens and GvHD prevention strategies, improving survival for younger AML patients.
- What could go wrong
- This is a large trial testing multiple approaches, so results may take years. Some treatments may not improve outcomes or could increase side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
CH Amiens Hôpital Sud
RECRUITINGAmiens, France
Contact
-
CH Beziers
RECRUITINGBéziers, France
Contact Email: •••••@•••••
-
CH Bordeaux
RECRUITINGBordeaux, France
Contact
-
CH Caen
RECRUITINGCaen, France
Contact
-
CH Dunkerque
RECRUITINGDunkirk, France
Contact
-
CH Hôtel Dieu
RECRUITINGNantes, France
Contact
-
CH Lens
RECRUITINGLens, France
Contact Email: •••••@•••••
-
CH Lyon Sud
RECRUITINGLyon, France
Contact
-
CH Meaux
RECRUITINGMeaux, France
Contact
-
CH Mulhouse
RECRUITINGMulhouse, France
Contact
-
CH Pontchaillou
RECRUITINGRennes, France
Contact
-
CH Valenciennes
RECRUITINGValenciennes, France
Contact
-
CH Versailles
RECRUITINGLe Chesnay, France
Contact
-
CH Victor Dupouy
RECRUITINGArgenteuil, France
Contact Email: •••••@•••••
-
CHR Metz Thionville_Hôpital de Mercy
RECRUITINGMetz, France
Contact Email: •••••@•••••
-
CHRU de Lille, Hôpital Huriez
RECRUITINGLille, France
Contact Email: •••••@•••••
-
CHRU de Nîmes
RECRUITINGNîmes, France
Contact Email: •••••@•••••
-
CHU Angers
RECRUITINGAngers, 49100, France
Contact Email: •••••@•••••
-
CHU Bretonneau
RECRUITINGTours, France
Contact Email: •••••@•••••
-
CHU Estaing
RECRUITINGClermont-Ferrand, France
Contact Email: •••••@•••••
-
CHU Nice
RECRUITINGNice, France
Contact
-
CHU de Dijon
RECRUITINGDijon, France
Contact Email: •••••@•••••
-
CHU de Limoges
RECRUITINGLimoges, France
Contact
-
CHU de Poitiers
RECRUITINGPoitiers, France
Contact
-
Centre Antoine Lacassagne
RECRUITINGNice, France
Contact
-
Centre Henri Becquerel
RECRUITINGRouen, France
Contact
-
Centre Hospitalier René Dubos
RECRUITINGCergy-Pontoise, France
Contact Email: •••••@•••••
-
Centre Hospitalier Saint Jean
RECRUITINGPerpignan, France
Contact Email: •••••@•••••
-
Centre Hospitalier Sud Francilien
RECRUITINGCorbeil-Essonnes, France
Contact Email: •••••@•••••
-
Centre Hospitalier de la Côte Basque
RECRUITINGBayonne, France
Contact
-
Centre Leon Berard (CLB)
RECRUITINGLyon, France
Contact Email: •••••@•••••
-
Clinique du parc
WITHDRAWNCastelnau-le-Lez, 34170, France
-
HIA Percy
RECRUITINGClamart, France
Contact
-
Hopital Victor Provo
RECRUITINGRoubaix, France
Contact
-
Hôpital Avicenne
RECRUITINGBobigny, France
Contact
-
Hôpital Cochin
RECRUITINGParis, France
Contact
-
Hôpital Hautepierre
RECRUITINGStrasbourg, France
Contact
-
Hôpital Henri Mondor
RECRUITINGCréteil, France
-
Hôpital Jean Minjoz
RECRUITINGBesançon, France
Contact
-
Hôpital La Pitié Salpêtrière
RECRUITINGParis, France
Contact
-
Hôpital Michallon
RECRUITINGGrenoble, France
Contact
-
Hôpital Morvan
RECRUITINGBrest, France
Contact Email: •••••@•••••
-
Hôpital Necker Enfants Malades
RECRUITINGParis, France
Contact
-
Hôpital René Huguenin
RECRUITINGSaint-Cloud, France
Contact
-
Hôpital Robert Debré
RECRUITINGReims, France
Contact Email: •••••@•••••
-
Hôpital Saint Antoine
RECRUITINGParis, France
Contact Email: •••••@•••••
-
Hôpital Saint Eloi
RECRUITINGMontpellier, France
Contact
-
Hôpital St Louis
RECRUITINGParis, France
Contact
-
Hôpital St Vincent de Paul
RECRUITINGLille, France
Contact
-
Hôpital du Dr Duchenne
RECRUITINGBoulogne-sur-Mer, France
Contact
-
Hôpitaux de Brabois_CHU Nancy
RECRUITINGVandœuvre-lès-Nancy, France
Contact Email: •••••@•••••
-
IUCT Toulouse
RECRUITINGToulouse, France
Contact
-
Institut Paoli Calmettes
RECRUITINGMarseille, France
Contact
-
Institut de Cancérologie Gustave Roussy
RECRUITINGVillejuif, France
Contact
-
Institut de Cancérologie Lucien Neuwirth
RECRUITINGSaint-Priest-en-Jarez, France
Contact
-
Marseille La Conception
RECRUITINGMarseille, 13005, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug cocktail aims to stop leukemia return after transplant
- New genetic test aims to sharpen blood cancer diagnosis
- New pill targets genetic weakness in Hard-to-Treat blood cancers
- Blood test may personalize leukemia drug dosing
- Engineered immune cells take on tough leukemia in early trial
- New drug combo aims to boost survival in aggressive leukemia